Abstract
Percutaneous coronary intervention of complex coronary artery disease remains challenging and is still associated with suboptimal cardiovascular outcomes. Over the years, different strategies and technologies have been developed to improve these results. Particularly, the development and evolution of intravascular imaging modalities to guide the procedure have improved lesion assessment and preparation, and stent optimization. However, whether these advantages are beneficial in this particular setting is still under discussion. In this article we intend to briefly summarize previous imaging-guided trials and give an outline on the ongoing large trials that are being conducted on imaging-guided interventions in complex coronary disease.
Original language | English |
---|---|
Pages (from-to) | 297-303 |
Number of pages | 7 |
Journal | REC: Interventional Cardiology |
Volume | 3 |
Issue number | 4 |
DOIs | |
Publication status | Published - Oct 2021 |
Bibliographical note
Funding Information:H.M. Garcia-Garcia, and K.O. Kuku declared having received Institutional grant support from Biotronik, Boston Scientific, Medtronic, Abbott Vascular, Neovasc, Shockwave, Phillips, and Corflow. R. Diletti also declared having received institutional grant support from Biotronik, and Boston Scientific. E. Fernández-Peregrina declared having received a research grant from Sociedad Española de Cardiología.
Publisher Copyright:
© 2021 American Phytopathological Society. All rights reserved.